CAR-T cell therapy could be a potential next step for you, especially if your myeloma is refractory (resistant to treatment) or relapsed (came back after being treated). Here are some key points about CAR-T cell therapy:

- Eligibility: Typically for those who have tried at least four other treatments, including read more

CAR-T cell therapy could be a potential next step for you, especially if your myeloma is refractory (resistant to treatment) or relapsed (came back after being treated). Here are some key points about CAR-T cell therapy:

- Eligibility: Typically for those who have tried at least four other treatments, including immunomodulatory drugs, proteasome inhibitors, and others.
- Process: T cells are collected, genetically modified to target cancer cells, and then infused back into the body.
- Effectiveness: Can reduce or eliminate signs of myeloma, even when other treatments have failed.
- Risks: Potentially serious side effects, and the cancer may sometimes return.

Consult with your healthcare provider to determine if this therapy is suitable for your specific condition.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam